Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trialBob W. van Oosten, Chris H. Polman, Mitchell K.P. Lai et al.|Neurology|1997Cited by 268
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter Mitchell, Justin Whitley, Steven Bush et al.|The Lancet|2022Cited by 225